PT-141 (bremelanotide) is a peptide-based therapy designed to stimulate sexual desire through the brain’s arousal centers. Administered via subcutaneous injection, it bypasses vascular pathways and works centrally—offering a unique and effective option for both men and women.

💗 Sexual Dysfunction Treatment

• For men: Supports erectile function—especially in those who don’t respond to PDE5 inhibitors like Viagra.

• For women: Helps treat Hypoactive Sexual Desire Disorder (HSDD) by increasing arousal and interest.

🧠 Central Nervous System Action
PT-141 activates melanocortin receptors in the brain, which play a key role in sexual desire—resulting in stronger, more spontaneous arousal.

🔥 Enhanced Libido & Satisfaction
Many users report noticeable improvements in libido, pleasure, and sexual confidence—without relying on blood flow alone.

⏱️ Rapid Onset of Action
Effects can be felt within minutes to an hour, making it an excellent option for those seeking flexibility and spontaneity.

💊 Alternative for Non-Responders
PT-141 offers a new solution for individuals who haven’t had success with traditional ED or arousal medications

PT-141 is ideal for adults who:
✅ Struggle with low libido or sexual desire
✅ Experience sexual dissatisfaction despite normal blood flow
✅ Want to feel more confident and connected with their partner
✅ Haven’t responded to traditional ED medications

PT-141 binds to melanocortin receptors in the brain, stimulating the neurological pathways responsible for sexual interest and arousal. Unlike oral ED drugs, PT-141 doesn’t depend on vascular function, making it ideal for patients with blood flow-related limitations.

• Mild redness, swelling, or soreness at injection site

• Rare: Headache, nausea, or digestive upset

• Seek immediate care for signs of allergic reaction (e.g., swelling, rash, difficulty breathing)

PT-141 is generally well-tolerated, but potential side effects may include:

• Mild nausea

• Headache

• Facial flushing

• Nasal irritation (especially with intranasal versions)

Contact your healthcare provider if side effects are severe or persistent.

Yes—when prescribed and monitored by a healthcare professional. PT-141 is FDA-approved for HSDD in women and commonly used off-label for men. Always consult your provider before starting any new therapy.